Massive Real-World study reveals how immunotherapy fights esophageal cancer
NCT ID NCT05142709
First seen Feb 05, 2026 · Last updated May 14, 2026 · Updated 11 times
Summary
This study looked at medical records from 1197 people in China with advanced esophageal cancer who received immunotherapy (anti-PD-1) plus chemotherapy as their first treatment. The goal was to see how long they lived and how well the treatment worked in everyday medical practice, not just in a controlled trial. The findings help doctors understand the real-world benefits of this combination therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anyang cancer hospital
Anyang, Henan, China
-
Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen Center
Shenzhen, Guangdong, China
-
Fudan University Shanghai cancer center
Shanghai, Shanghai Municipality, 200032, China
-
Fujian Cancer Hospital & Fujian Medical University Cancer Hospital
Fuzhou, Fujian, China
-
Henan Cancer Hospital
Zhengzhou, Henan, China
-
Huai'an first hospital
Huai'an, Jiangsu, China
-
Jiangsu cancer Hosipital
Nanjing, Jiangsu, China
-
Jiangxi Cancer Hospital
Nanchang, Jiangxi, China
-
Nantong cancer hospital
Nantong, Jiangsu, China
-
Sichuan cancer hospital
Chengdu, Sichuan, China
-
The 1st affiliated hospital of Nanchang University
Nanchang, Jiangxi, China
-
The 1st affiliated hospital of Xiamen University
Xiamen, Fujian, China
-
The 2nd affiliated hospital of Bengbu medical University
Bengbu, Anhui, China
-
The 2nd affiliated hospital of Nanchang University
Nanchang, Jiangxi, China
-
The 2nd affiliated hospital of Wenzhou medical university
Wenzhou, Zhejiang, China
-
The 2nd people's hospital of Anhui province
Hefei, Anhui, China
-
The 4th affiliated hospital of Hebei Medical University
Shijiazhuang, Hebei, China
-
The First Affiliated Hospital of Air Force Medical University
Xi'an, Shaanxi, China
-
The Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, China
-
Wuhan University Zhongnan hospital
Wuhan, Hubei, China
-
Yancheng the 3rd hospital
Yancheng, Jiangsu, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
-
Zhongnan University Xiangya Hospital
Changsha, Hunan, China
Conditions
Explore the condition pages connected to this study.